CATALOGO DEI PRODOTTI DELLA RICERCA

CIPRIANI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.193
EU - Europa 8.107
AS - Asia 5.145
SA - Sud America 986
AF - Africa 70
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 11
Totale 22.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.079
RU - Federazione Russa 2.333
GB - Regno Unito 2.332
SG - Singapore 2.267
CN - Cina 1.543
IT - Italia 831
BR - Brasile 818
FR - Francia 586
HK - Hong Kong 512
FI - Finlandia 476
DE - Germania 458
IE - Irlanda 385
VN - Vietnam 366
SE - Svezia 346
UA - Ucraina 155
KR - Corea 134
AR - Argentina 68
CA - Canada 62
TR - Turchia 53
ID - Indonesia 50
NL - Olanda 43
IN - India 38
JP - Giappone 36
MX - Messico 32
BD - Bangladesh 31
EC - Ecuador 27
AT - Austria 24
ES - Italia 22
AU - Australia 20
IL - Israele 20
PL - Polonia 20
RO - Romania 18
BE - Belgio 17
PY - Paraguay 16
ZA - Sudafrica 16
IQ - Iraq 15
UY - Uruguay 15
PE - Perù 13
CO - Colombia 12
KE - Kenya 11
CH - Svizzera 9
EG - Egitto 9
EU - Europa 9
CL - Cile 8
HU - Ungheria 8
MA - Marocco 8
AZ - Azerbaigian 7
DZ - Algeria 7
JO - Giordania 7
KZ - Kazakistan 7
PK - Pakistan 7
GR - Grecia 6
UZ - Uzbekistan 6
VE - Venezuela 6
BG - Bulgaria 5
BY - Bielorussia 5
HN - Honduras 5
IR - Iran 5
PH - Filippine 5
PT - Portogallo 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
LB - Libano 3
LT - Lituania 3
SI - Slovenia 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
ET - Etiopia 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
KG - Kirghizistan 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 22.519
Salva come PNG Salva come JPEG
Città #
Southend 2.103
Jacksonville 1.298
Singapore 988
Woodbridge 967
Chandler 841
Dallas 675
Moscow 627
Ann Arbor 580
Houston 552
Hong Kong 509
Dublin 385
Ashburn 333
Beijing 259
Wilmington 222
Lawrence 216
Princeton 216
Verona 155
New York 149
Nanjing 128
Ho Chi Minh City 121
Jinan 111
Los Angeles 110
The Dalles 105
Shenyang 104
Buffalo 100
Milan 96
Hebei 73
São Paulo 70
Hanoi 67
Redondo Beach 61
Munich 58
Dong Ket 56
Helsinki 52
Tianjin 49
Changsha 48
Sindelfingen 47
Nanchang 45
Rome 43
Haikou 40
Boardman 39
Hangzhou 36
Ningbo 36
Columbus 34
Washington 34
Guangzhou 32
Norwalk 31
Dearborn 30
Redwood City 30
Santa Clara 29
Taiyuan 29
Zhengzhou 28
Bologna 26
Jiaxing 26
London 25
San Francisco 25
Taizhou 25
Tokyo 25
Turku 24
Toronto 22
Lancaster 21
Belo Horizonte 20
Council Bluffs 19
Brasília 18
Rio de Janeiro 18
Stockholm 18
Chicago 17
Jakarta 16
Florence 15
Fuzhou 15
Mexico City 15
Brussels 14
Manchester 14
Montreal 14
Shanghai 14
Düsseldorf 13
Falls Church 13
Frankfurt am Main 13
Montevideo 13
Warsaw 13
Brooklyn 12
Campinas 12
Lanzhou 12
Nuremberg 12
Porto Alegre 12
Vienna 12
Curitiba 11
Guayaquil 11
Naples 11
Amsterdam 10
Chennai 10
Haiphong 10
Lima 10
Orem 10
Seattle 10
Ankara 9
Asunción 9
Atlanta 9
Fairfield 9
Guarulhos 9
Nairobi 9
Totale 13.777
Salva come PNG Salva come JPEG
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 516
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 377
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 271
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 210
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 193
Assessing risk of bias in randomized controlled trials 175
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 172
Antidepressants and benzodiazepines for panic disorder in adults 170
"Wish bias" in antidepressant drug trials? 165
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 163
Allocation concealment and blinding in clinical trials 163
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 163
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 161
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 158
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 157
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 157
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 155
Antidepressive Monotherapie 154
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 151
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 150
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 149
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 148
Agomelatine and the brave old world of narrative-based medicine 148
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 143
What is a run-in phase? 142
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 141
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 140
Are all antidepressants really the same? The case of fluoxetine: a systematic review 138
Antidepressants for Bipolar Disorder 138
Implementation of treatment guidelines for specialist mental health care 138
Sertraline versus other antidepressive agents for depression 136
Associazione tra TCA e SSRI nella depressione resistente 135
What is a systematic review? 135
Azapirones versus placebo for panic disorder in adults 135
Citalopram versus other anti-depressive agents for depression 134
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 133
A primer on network meta-analysis with emphasis on mental health 133
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 132
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis 132
Randomized trials published in Chinese or Western journals: comparative empirical analysis 131
Benzodiazepines and risk of dementia: true association or reverse causation? 131
Imputing missing standard deviations in meta-analyses can provide accurate results 130
Citalopram versus other anti-depressive agents for depression 130
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 128
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 128
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 127
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 127
Antidepressants in unipolar major depression: what we need to know 127
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 125
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis 125
What is a forest plot? 124
Profilo di efficacia e tollerabilità dell'escitalopram rispetto agli altri farmaci antidepressivi nel trattamento acuto della depressione maggiore: revisione sistematice e meta-analisi. [Efficacy and tolerability profile of escitalopram versus other antidepressants in the acute treatment of major depressive disorder: A systematic review and meta-analysis] 123
Duloxetine versus other anti-depressive agents for depression 123
Citalopram versus other anti-depressive agents for depression. 123
Implementation of treatment guidelines for specialist mental health care 123
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 123
Seven criteria for improving effectiveness trials in psychiatry 122
What is a risk ratio? 122
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 121
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development 121
Levels of evidence: can quality of systematic reviews be quantified? 120
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 118
Advancing evidence-based practice to improve patient care 118
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation 116
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology 116
Conventional vs. atypical antipsychotic medications [Letter] 115
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 115
Implementation of treatment guidelines for specialist mental health care 115
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 114
Depressive disorders 113
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 113
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 112
Paroxetine versus other anti-depressive agents for depression 112
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials 110
Fluoxetine versus other types of pharmacotherapy for depression (Review) 109
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 109
Superiority, equivalence or non-inferiority? 108
Sertraline versus other antidepressive agents for depression 108
Outcome reporting bias in clinical trials 107
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 107
What is a clinical trial protocol? 106
What is an individual patient data meta-analysis? 105
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 104
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 103
Does the addiction of a second antipsychotic drug improve clozapine treatment? 103
Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants 102
Review: atypical antipsychotics are effective adjuncts for treatment resistant depression but increase discontinuation due to adverse effects 102
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 101
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 101
Mirtazapine versus other antidepressive agents for depression 100
Commentary on: Analysis and reporting of factorial trials: a systematic review (McAlister et al., JAMA) 99
Validity of the impact factor of journals as a measure of randomised controlled trial quality 99
Haloperidol alone or in combination for acute mania 98
Olanzapine in long-term treatment for bipolar disorder (Protocol for a Cochrane Review) 98
What is an intention to treat analysis? 98
What is a multiple treatments meta-analysis? 98
What is a randomised controlled trial? 97
Risk of suicidal behaviour in adults taking antidepressants 97
Fluoxetine versus other types of pharmacotherapy for depression (Protocol for a Cochrane Review) 96
What is a factorial trial? 96
Totale 13.503
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.749
article - articoli 72.991
book - libri 338
conference - conferenze 0
curatela - curatele 0
other - altro 1.984
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.436
Totale 155.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021967 0 0 0 0 226 192 18 147 127 23 137 97
2021/20221.254 72 282 25 57 42 29 12 91 60 31 140 413
2022/20232.732 253 166 332 431 290 572 33 183 320 30 70 52
2023/20241.351 71 129 111 118 162 187 47 92 19 83 190 142
2024/20253.814 285 251 171 554 177 137 216 178 566 280 225 774
2025/20265.451 768 624 838 1.487 1.734 0 0 0 0 0 0 0
Totale 22.663